4553 — Towa Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Towa Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	C2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	18,713	22,915	32,830	24,257	29,650
Net Total Accounts Receivable
Net Total Receivables	41,572	45,784	50,748	54,392	71,657
Total Inventory
Total Other Current Assets
Total Current Assets	121,525	137,290	166,864	182,990	217,718
Net Property, Plant And Equipment	81,629	85,898	99,873	127,004	153,642
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	230,016	245,668	332,097	371,347	430,653
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70,164	51,516	115,073	78,529	80,118
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	125,351	129,069	199,928	234,453	274,760
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	104,665	116,599	132,169	136,894	155,893
Total Liabilities & Shareholders' Equity	230,016	245,668	332,097	371,347	430,653
Total Common Shares Outstanding